Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Athersys Inc (NQ: ATHX )

2.290 USD +0.140 (+6.51%)
Streaming Delayed Price Updated: 7:50 AM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Athersys Inc

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Athersys to Present at 12th Annual BIO CEO & Investor Conference
From GlobeNewswire News Releases
Athersys Files Shelf Registration Statement
From GlobeNewswire News Releases
NASDAQ OMX Expands Agreement With Morningstar to Provide Comprehensive Equity Research Coverage on NASDAQ-Listed Companies
From GlobeNewswire News Releases
Rising Housing Sales Boost Stocks
Home resales jumped 7.3% in November, according to the National Association of Realtors. Investors remained optimistic about the economy recovery as the Dow rose 50 points to close at 10,464. Nasdaq... 
Tags Market News
From MarketMinute.com Market Updates
Athersys Continues Rally
Shares of Athersys Inc. (Nasdaq: ATHX) continued to rally by leaping $2.72 to $5.12 following an analyst upgrade for its partnership with Pfizer Inc. (NYSE: PFE) to develop stem cell treatments. Pfizer... 
From MarketMinute.com Stock News
Drug stocks gain; Athersys soars for second day
BOSTON (MarketWatch) -- Drug stocks advanced early Tuesday as shares of Athersys Inc. soared for the second day following news it has entered into a collaboration with Pfizer Inc. for its stem-cell... 
Tags Biotechnology GENZ $BTK
From MarketWatch
Stocks Open Higher on Modest Economic Growth Report
3rd quarter GDP was revised downward by the Commerce Department to a 2.2% pace, but investors remained convinced that the economic recovery remained on track. The Dow rose 39 points to 10,453 while... 
Tags Market News
From MarketMinute.com Market Updates
Athersys to Produce Stem-Cell Treatment with Pfizer
Bio-pharmaceutical company Athersys, Inc. has struck a deal with Pfizer to develop and market stem-cell treatments for irritable bowel disease. 
Tags Health Care
From FOX Business
Drug stocks climb; Athersys soars on Pfizer deal
BOSTON (MarketWatch) -- Drug stocks climbed in early action, following the broader market north, as shares of Athersys Inc. soared on news it has signed a deal with Pfizer Inc. for its stem-cell... 
Tags Company Announcements $DRG INCY
From MarketWatch
Monday's biggest gaining and declining stocks
Stocks expected to move significantly in Monday's trading include the retailers, whose operations took a hit because of the massive weekend snowstorm in the U.S. Northeast. In addition, investors can... 
Tags BAC C ENSG
From MarketWatch
Athersys Enters Into Global Agreement With Pfizer to Develop and Market MultiStem(R) for the Treatment of Inflammatory Bowel Disease
Athersys to Host Conference Call Today at 11:00 AM EST to Discuss Stem Cell Partnership 
From GlobeNewswire News Releases
Athersys Reports 2009 Third Quarter Results
MultiStem Programs Continue to Progress 
From GlobeNewswire News Releases
Athersys to Host Third Quarter 2009 Financial Results Call
From GlobeNewswire News Releases
Athersys Reports 2009 Second Quarter Results
MultiStem Programs Continue to Progress 
From GlobeNewswire News Releases
StockPreacher.com Issues Trading Outlook for Orexigen Therapeutics Inc.
From GlobeNewswire News Releases
Athersys to Host Second Quarter 2009 Financial Results Call
From GlobeNewswire News Releases
Athersys Reports 2009 First Quarter Results
MultiStem Programs and Pipeline Continue to Advance 
From GlobeNewswire News Releases
Athersys to Host First Quarter 2009 Financial Results Call
From GlobeNewswire News Releases
Reminder: Athersys' First Annual Investor Day On April 8, 2009 in New York City
From GlobeNewswire News Releases
Athersys to Present At Cowen and Company 29th Annual Health Care Conference
From GlobeNewswire News Releases
Athersys Reports Fourth Quarter and 2008 Annual Results
Company Makes Continued Progress in Development of MultiStem(r) and Product Pipeline 
From GlobeNewswire News Releases
Athersys to Host First Annual Investor Day to Highlight Progress in Stem Cell and Drug Development Programs
From GlobeNewswire News Releases
Athersys to Host Fourth Quarter 2008 Financial Results Call
From GlobeNewswire News Releases
Athersys to Present At 4th Annual Stem Cell Summit
From GlobeNewswire News Releases
Athersys to Present At 5th Annual Cell and Gene Therapy Forum
From GlobeNewswire News Releases
Athersys Receives IND Authorization for Multistem in Treatment of Ischemic Stroke
Third IND for Company's Proprietary Stem Cell Product in Less Than a Year 
From GlobeNewswire News Releases
Athersys to Present At Lambert-Edwards SMID-West Stock Conference
From GlobeNewswire News Releases
Athersys to Participate At RBC Capital Markets 2008 Healthcare Conference
From GlobeNewswire News Releases
Athersys Announces Clinical Development Milestone in Bristol-Myers Squibb Discovery Alliance
From GlobeNewswire News Releases
Athersys to Present At Lazard Capital Markets Annual Healthcare Conference
From GlobeNewswire News Releases
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.